Stroke prevention: Windows of opportunity and failed expectations?

Neuroepidemiology

Volumn 16, Issue 4, 1997, Pages 163-173

  Gorelick, Philip B ^a  

^a RUSH MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL CONSUMPTION; HEART INFARCTION; HUMAN; HYPERTENSION; PREVENTIVE MEDICINE; REVIEW; RISK FACTOR; SMOKING; STROKE;

EID: 0030846507     PISSN: 02515350     EISSN: 14230208     Source Type: Journal    
DOI: 10.1159/000109683     Document Type: Article

References (63)

1. Gorelick PB: Stroke prevention. An opportunity for efficient utilization of health care resources during the coming decade. Stroke I994;25: 220-224.
2. Gorelick PB: Stroke prevention. Arch Neurol 1995;52:347-355.
3. Wolf PA. Belanger AJ. D’agostino RB: Management of risk factors. Neurol Clin 1992;10:177-191.
4. Kannel WB: Blood pressure as a cardiovascular risk factor. Prevention and treatment. JAMA 1996;275: 1571-1576.
5. Lassen NA: Epidemiologic assessment of the role of blood pressure in stroke. JAMA 1996:276:1279-1280.
6. Manson JE, Tosteson H. Satterfield S. Hebert P, O’connor GT. Burning JE, Hcnnekcns CH: The primary prevention of myocardial infarction. N Engl J Med 1992:326:1406-1416.
7. The National Institute of Neurological Disorders and stroke r-PA Stroke Study Group: Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995:333:1581-1587.
8. Wolf PA: Commentary on ischemic stroke. In: Gorelick PB. Alter MA (cds): Handbook of Ncuroepidemio-logy. New York, Dekker, 1994, pp 120-121.
9. Working Group Report on Primary Prevention of Hypertension: National High Blood Pressure Education Program. Bcthesda, MD: National Institutes of Heart, Lung and Blood Institute document 93-2669.
10. Joint National Committee on Detection Evaluation and Treatment of High Blood Pressure. Arch Intern Med 1988;148:1023-1038.
11. Whelton PK, He J, Appel U: Treatment and prevention of hypertension; in Manson JE, Ridker PM, Ga-zianoJM. HennekensCH(eds): Prevention of Myocardial Infarction. New York, Oxford University Press. 1996. pp 154-171.
12. He J, Klag MJ, Whelton PK, Chen J-Y, Mo J-P. Qian M-C. Mo P-S, He G-Q: Migration, blood pressure pattern and hypertension: The Yi Migrant Study. Am J Epidemiol 1991; 134:1085-1101.
13. Centers for Disease Control: Cigarette smoking among adults -United States 1990. MMWR 1992; 41:354-355.
14. Nelson DE, Giovino GA, Shopland DR. Mowery PD. Mills SL. Erikson MP: Trends in cigarette smoking among US adolescents, 1974-1991. Am J Public Health 1995;85:34-40.
15. Emstcr VL: Women and smoking. Am J Public Health 1993;82:1202-1203.
16. Bartccchi CE, Mackenzie TD, Schricr RW: The human costs of tobacco use. N Engl J Med 1994; 330:907-912.
17. Peto R, Lopez AD. Borcham J, Thun M, Health C, Jr.: Mortality from tobacco in developed countries: indirect estimation from national statistics. Lancet 1992;339: 1268-1278.
18. IS Grant BF, Harford TC, Chou P, Pickering R, Dawson DA. Stinson FS, Noble J: Prevalenceof DSM-III-R alcohol abuse and dependence: United States. 1988. Alcohol Health Res World 1991;15:91-96.
19. Archer L, Grant BF. Dawson DA: What if Americans drank less? The potential effect on the prevalence of alcohol abuse and dependence. Am J Public Health 1995;85:61-66.
20. Klatsky AL, Friedman GD: Annotation: Alcohol and longevity. Am J Public Health 1995;85:16-18.
21. Gorelick PB: Status of alcohol as a risk factor for stroke. Stroke 1989; 20:1607-1610.
22. Gorelick PB: Does alcohol prevent or cause strokes? Opinion No. 4. Cerebrovasc Dis 1995;5:379.
23. Sempos C, Fuhvood R, Haines C, Carroll M, Anda R, Williamson DF, Remington P. Clecman J: The prevalence of high blood cholesterol levels among adults in the United States. JAMA 1989;262:45-52.
24. Johnson CL, Rifkind BM, Sempos CT. Carroll MD, Bachorik PS, Brie-fel RR. Gordon DJ. Burt VL, Brown CD. Lippcl K. Clecman J: Declining serum total cholesterol levels among US adults: The National Health and Nutrition Examination Surveys. JAMA 1993;269:3002-3008.
25. Manson JE, Gaziano JM, Ridker PM, Hcnnekcns CH: Myocardial infarction: Epidemiologic overview; in Manson JE, Ridker PM, Gaziano JM. Hennekens CH (eds): Prevention of Myocardial Infarction. New York. Oxford University Press, 1996, pp 3-31.
26. Kuczmarski RJ. Flcgal KM, Campbell SM. Johnson CL: Increasing prevalence of overweight among US adults: The National Health Examination Survcvs. 1960 to 1991. JAMA 1994:272:205-211.
27. Centers for Disease Control: Prevalence of sedentary lifcstylc-Bchav-ioral Risk Factor Surveillance, United States. 1991. MMWR 1993; 42:576-579.
28. Pate RR. Pratt M, Blair SN, Haskell WL, Macéra CA, Bouchard C, Buchner D, Ettinger W, Heath GW, King AC, Kriska A, Leon AS, Marcus BH, Morris J, Paffcnbarger RS, Patrick K. Pollock ML, Rippe JM, Sallis J, Wilmorc JH: Physical activity and public health. A recommendation from the Centers for Disease Control and Prevention and the American College of Sports Medicine. JAMA 1995;273:402-407.
29. Bronner LL, Kanter DS, Manson JE: Primary prevention of stroke. N Engl J Med 1995;333:21:1392-1400.
30. Dunbabin DW, Sandercock PAG: Preventing stroke by modification of risk factors. Stroke 1990;21 (suppl 4):IV36-IV39.
31. Collins R, Peto R. MacMahon S, Hebert P, Fiebach NH, Eberlein KA. Godwin J, Qizilbash N, Taylor JO, Hennekens CH: Blood pressure, stroke, and coronary heart disease. 2. Short-term reductions in blood pressure: overview of randomized drug trials in their epidemiologic context. Lancet 1990;335:827-838.
32. Atkins D. Psaty BM. Kocpscll TD, Longstreth WT, Larson EB: Cholesterol reduction and the risk for stroke in men: A meta-analysis of randomized, controlled trials. Ann Intern Med 1993;119:136-145.
33. Gould AL. Rossouw JE. Santancllo NC, Hcysc JF, Furbcrg CD: Cholesterol reduction yields clinical benefit. A new look at old data. Circulation 1995;91:2274-2282.
34. Shinton R. Bcevers G: Meta-analysis of relation between cigarette smoking and stroke. BMJ 1989:298: 789-794.
35. D’agostino RB, Wolf PA, Belanger AJ, Kännel WB: Stroke risk profile: adjustment for antihypertensive medication: the Framingham study. Stroke 1994;25:40-43.
36. Camargo CA Jr.: Moderate alcohol consumption and stroke: the epidemiologic evidence. Stroke 1989;20: 1611-1626.
37. Whisnant JP: Changing incidence and mortality rates for stroke. J Stroke Cerebrovasc Dis 1992;2:42-44.
38. Whclton PK, Brancati FL: Hypertension management in populations. Clin Exp Hypertcns 1993:15:1147-1156.
39. Whisnant JP: Effectiveness versus efficacy of treatment of hypertension for stroke prevention. Neurology 1996;46:301-307.
40. Hays JT, Hurl RD, Dale LC: Smoking Cessation; in Manson JE, Ridker PM, Gaziano JM, Hennekens CH (eds): Prevention of Myocardial Infarction. New York. Oxford University Press, 1996, pp 99-129.
41. Daly PA, Solomon CG, Manson JE: Risk Modification in the Obese Patient; in Manson JE, Ridker PM, Gaziano JM. Hennekens CH (eds): Prevention of Myocardial Infarction. New York, Oxford University Press. 1996, pp 203-240.
42. Hiss RG: Barriers to care in non-insulin-dcpcndent diabetes mellitus. Ann Intern Med 1996; 124(l pt 2): 146-148.
43. Goldstein LB, Bonito AJ, Matchar DB. Duncan PW. Samsa GP: National survey of physician practices for the secondary and tertiary prevention of ischemic stroke. Medical therapy in patients with carotid artery stenosis. Stroke 1996:27:1473-1478.
44. Holloway RG: Cost-effectiveness analysis: What is it and how will it influence neurology? Neurology 1996;39:818-823.
45. Rose G: The Strategy of Preventive Medicine. New York, Oxford University Press, 1994, pp 1-138.
46. NIH Consensus Development Panel on Physical Activity and Cardiovascular Health: Physical activity and cardiovascular health. JAMA 1996; 276:241-246.
47. Paffenbarger RS, Wing AL, Hyde RT: Physical activity as an index of heart attack risk in college alumni. Am J Epidemiol 1978; 108:161-175.
48. Fiscclla K, Franks P: Cost-effectiveness of the transdermal nicotine patch as an adjunct to physicians’ smoking cessation counseling. JAMA 1996:1247-1251.
49. Wolf PA, D’agostino RB, Kannel WB, Bonita R, Belanger AJ: Cigarette smoking as a risk factor for stroke: the Framingham Study. JAMA 1988;259:1025-1029.
50. Donahue RP, Abbott RD, Reed DM, Yano K: Alcohol and hemorrhagic stroke. The Honolulu Heart Program. JAMA 1986;255:2311-2314.
51. Garber AM. Browner WS. Hulley SB: Cholesterol screening in asymptomatic adults, revisited. Ann Intern Med 1996;124:518-531.
52. Dcnke MA, Winker MA: Cholesterol and coronary heart disease in older adults. No easy answers. JAMA 1995;274:575-577.
53. SHEP Cooperative Research Group: Prevention of stroke by anti-hypertensive drug treatment in older adults with isolated hypertension: Final Results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA 1991:256:3255-3264.
54. 1993 Joint National Committee: The 5th Report of the Joint National Committee on the Detection, Evaluation and Treatment of High Blood Pressure (JNC V). Arch Intern Med 1993;153:154-183.
55. Midgley JP, Matthew AG, Greenwood CM, Logan AG: Effect of reduced dietary sodium on blood pressure. A meta-analysis of randomized controlled trials. JAMA I996;275: 1590-1597.
56. Gorelick PB, Harris Y: Stroke: An excess burden on African-Americans. Chicago Med 1993;96:28-30.
57. Winklcby MA. Taylor CB, Jatulis D. Fortmann SP: The long-term effects of a cardiovascular disease prevention trial: The Stanford Five-City Project. Am J Public Health 1996;86:1773-1779.
58. Feinlcib M: New directions for community intervention studies (editorial). Am J Public Health 1996;56: 1696-1697.
59. Hokkancn E: Neurology as an important part of public health care sendee. The Finnish model. Proc 2nd Int Conf Organization Delivery Neurol Services ‘Neurology Update 2000’. Neurol Croat I996;45(suppl 3):4-5.
60. The American Cancer Society 1996 Advisory Committee on Diet, Nutrition, and Cancer Prevention: Guidelines on diet, nutrition, and cancer prevention: reducing the risk of cancer with healthy food choices and physical activity. CA Cancer J Clin 1996:46:325-341.
61. Kamachi I. Colditz GA, Stampfer MJ, Willett WC, Masson JE, Rosncr B, el al: Smoking cessation and decreased risk of stroke in women. JAMA 1993;269:232-236.
62. Scandinavian Simvastatin Survival Study Group: Randomized trial of cholesterol lowering in 4,444 patients with coronary heart disease: the Scandinavian Simvastatin survival study (4S). Lancet 1994:344: 1383-1389.
63. Gillum RF. Mussolino ME. Ingram DD: Physical activity and stroke incidence in women and men. The NHANES 1 Epidemiologic Follow-Up Study. Am J Epidemiol 1996; 143:860-869.